Inventor · disambiguated record
Marvin Siegel
Also filed as: SIEGEL MARVIN · SIEGEL MARVIN I · SIEGEL MARVIN J
26 granted patents·8 pending applications·508 citations·filing 1982–2014
97Inventor score
Files withSCHERING CORP15STRESSGEN BIOTECHNOLOGIES CORP8NVENTA BIOPHARMACEUTICALS CORP2SPECIGEN INC2BURROUGHS WELLCOME CO1
Top patents by PatentIndex Score
34 records- 0191US6495347B1Induction of a Th1-like response in vitroSTRESSGEN BIOTECHNOLOGIES CORP·Filed 2000·Granted Dec 17, 2002·47 cites·64 claims
- 0291US5116840APolycyclic quinoline, naphthyridine and pyrazinopyridine derivativesSCHERING CORP·Filed 1990·Granted May 26, 1992·45 cites·8 claims
- 0391US5037826A1-substituted naphthyridine and pyridopyrazine derivativesSCHERING CORP·Filed 1986·Granted Aug 6, 1991·36 cites·27 claims
- 0490US6797491B2Human papilloma virus treatmentSTRESSGEN BIOTECHNOLOGIES CORP·Filed 2003·Granted Sep 28, 2004·51 cites·35 claims
- 0588US6657055B2Induction of a Th1-like response in vitroSTRESSGEN BIOTECHNOLOGIES CORP·Filed 2002·Granted Dec 2, 2003·28 cites·54 claims
- 0686US4448783ASubstituted pyrazoline, and its use in treatment of gastro-intestinal disturbancesBURROUGHS WELLCOME CO·Filed 1982·Granted May 15, 1984·16 cites·20 claims
- 0781US5182543AMiniaturized data communication and identification systemUNIV MICHIGAN STATE·Filed 1990·Granted Jan 26, 1993·110 cites·16 claims
- 0880US7157089B1Immune responses using compositions containing stress proteinsSTRESSGEN BIOTECHNOLOGIES CORP·Filed 1997·Granted Jan 2, 2007·53 cites·60 claims
- 0979US5439916APolycyclic quinoline, naphthyridine and pyrazinopyridine derivativesSCHERING CORP·Filed 1990·Granted Aug 8, 1995·19 cites·11 claims
- 1079US5126352APolycyclic quinoline, naphthyridine and pyrazinopyridine derivativesSCHERING CORP·Filed 1990·Granted Jun 30, 1992·19 cites·13 claims
- 1176US7754449B2Human papilloma virus treatmentNVENTA BIOPHARMACEUTICALS CORP·Filed 2007·Granted Jul 13, 2010·3 cites·25 claims
- 1276US7211411B2Human papilloma virus treatmentNVENTA BIOPHARMACEUTICALS CORP·Filed 2004·Granted May 1, 2007·10 cites·22 claims
- 1374US6921534B2Hepatitis B virus treatmentSTRESSGEN BIOTECHNOLOGIES CORP·Filed 2002·Granted Jul 26, 2005·6 cites·70 claims
- 1468US9302531B2Method and apparatus for producing a custom sized canvas stretcher frameSIEGEL MARVIN·Filed 2014·Granted Apr 5, 2016·3 cites·12 claims
- 1565US4988705APolycyclic quinoline, naphthyridine and pyrazinopyridine derivativesSCHERING CORP·Filed 1989·Granted Jan 29, 1991·6 cites·19 claims
- 1663US4564626AMethods of inducing bronchodilationSCHERING CORP·Filed 1983·Granted Jan 14, 1986·23 cites·2 claims
- 1762US2007160620A1Immune responses using compositions containing stress proteinsMIZZEN LEE·Filed 2006·Application pending·0 cites
- 1862US2005152917A1Hepatitis B virus treatmentSTRESSGEN BIOTECHNOLOGIES CORP·Filed 2004·Application pending·0 cites
- 1960US2005202044A1Immune responses using compositions containing stress proteinsSTRESSGEN BIOTECHNOLOGIES CORP·Filed 2004·Application pending·0 cites
- 2059US4882332AImmune suppression method employing arly-substituted naphthyridine and pyridopyrazine derivativesSCHERING CORP·Filed 1986·Granted Nov 21, 1989·5 cites·13 claims
- 2158US2009035389A1Targeted protein cagesSPECIGEN INC·Filed 2008·Application pending·0 cites
- 2255US4775686ANaphthyridine derivatives and method for treating allergic reactionsSCHERING CORP·Filed 1986·Granted Oct 4, 1988·4 cites·25 claims
- 2354US4810708APolycyclic quinoline, naphthyridine and pyrazinopyridine derivativesSCHERING CORP·Filed 1987·Granted Mar 7, 1989·4 cites·36 claims
- 2453US2005089841A1Induction of a Th1-like response in vitroSTRESSGEN BIOTECHNOLOGIES CORP·Filed 2003·Application pending·0 cites
- 2550US4725596APyrimidine derivatives having anti-allergy, anti-inflammatory and immuno suppressant activitySCHERING CORP·Filed 1986·Granted Feb 16, 1988·3 cites·14 claims
- 2649US2008311145A1Protein cage immunotherapeuticsSPECIGEN INC·Filed 2008·Application pending·0 cites
- 2746US2002110566A1Human papilloma virus treatmentFiled 2001·Application pending·0 cites
- 2840US2011142873A1Bioactive purified hspe7 compositionsROWSE GERRY·Filed 2007·Application pending·0 cites
- 2939US4916131ANaphthyridine derivatives and method for treating allergic reactionsSCHERING CORP·Filed 1988·Granted Apr 10, 1990·1 cites·22 claims
- 3038US4801589AMethod for suppressing the immune responseSCHERING CORP·Filed 1986·Granted Jan 31, 1989·6 cites·28 claims
- 3137US4666922AMethod for modulating the immune responseSCHERING CORP·Filed 1986·Granted May 19, 1987·5 cites·19 claims
- 3235US4687774AMethod for suppressing the immune responseSCHERING CORP·Filed 1986·Granted Aug 18, 1987·4 cites·18 claims
- 3332US5045542AImmune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivativesSCHERING CORP·Filed 1989·Granted Sep 3, 1991·0 cites·12 claims
- 3423US4945095AMethod for suppressing the immune responseSMITH SIDNEY R·Filed 1985·Granted Jul 31, 1990·1 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Marvin Siegel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →